Global Portal Hypertension Management Market
Healthcare Services

Top 5 Insights From The Portal Hypertension Management Market Report 2024

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Portal Hypertension Management Global Market Report 2024, the portal hypertension management market is expected to show promising growth in the forecast period.

Current Market Overview

The portal hypertension management market has experienced robust growth in recent years. As of 2023, the market size was $2.88 billion and is projected to grow to $3.07 billion in 2024. This represents a compound annual growth rate (CAGR) of 6.5%.

The factors driving this growth include:

  • Increased Liver Disease Prevalence: The rise in liver diseases such as hepatitis.
  • Aging Population: Growth in the geriatric demographic.
  • Awareness and Screening Programs: Increased public and professional awareness.
  • Economic Burden: Rising costs associated with liver diseases.
  • New Drug Approvals: Introduction of new treatments and therapies.
  • Diagnostic Advances: Improved diagnostic techniques.

Future Growth Prospects

Looking ahead, the portal hypertension management market is expected to reach $3.97 billion by 2028, with a CAGR of 6.7%.

This anticipated growth is supported by:

  • Investment in Healthcare Infrastructure: Increased funding and development.
  • Broader Health Insurance Coverage: Expanding access to treatments.
  • Favorable Regulatory Environments: Accelerated drug and therapy approvals.
  • Ongoing Research and Development: Focus on understanding portal hypertension.
  • Remote Monitoring Technologies: Enhanced patient management through technology.

View More On The Portal Hypertension Management Market Report 2024 – https://www.thebusinessresearchcompany.com/report/portal-hypertension-management-global-market-report

Key Trends for 2024-2028

  • Telemedicine Adoption: Rising use of remote healthcare services.
  • Advancements in Medical Technology: Innovations like bio-engineered liver tissue.
  • Personalized Medicine: Development of targeted therapies.
  • Enhanced Diagnostic Methods: Non-invasive imaging technologies like elastography.

Impact of Rising Liver Disease Prevalence

The growing prevalence of liver diseases, including hepatitis, is a significant driver of the portal hypertension management market.

Liver diseases can lead to severe complications, including:

  • Jaundice, Fatigue, and Abdominal Pain: Common symptoms of liver disorders.
  • Complications: Such as variceal bleeding and hepatic encephalopathy.

For instance, in September 2022, Australia reported approximately 2,905 new liver cancer cases. The risk of developing liver cancer by age 85 is significant, further emphasizing the need for effective management strategies.

Adoption of Minimally Invasive Devices

Advancements in minimally invasive technologies are revolutionizing portal hypertension management. These devices offer:

  • Reduced Procedural Risks: Minimal disruption to surrounding tissues.
  • Improved Outcomes: Enhanced treatment efficacy.

For example, in November 2023, Medtronic received FDA approval for the Symplicity Spyral renal denervation device. This device uses radiofrequency energy to treat hypertension, showcasing the innovation in minimally invasive treatments.

Strategic Acquisitions and Market Expansion

AstraZeneca’s acquisition of CinCor Pharma Inc. in February 2023 for $1.8 billion highlights the strategic moves within the industry. This acquisition enhances AstraZeneca’s cardiorenal and hypertension pipeline with:

  • New Treatments: Barostat (CIN-107) for treatment-resistant hypertension.
  • Pipeline Diversification: Expanding the range of therapeutic options.

Market Segmentation

The portal hypertension management market is segmented as follows:

  1. By Treatment Type:
    • Medications
    • Non-Surgical Procedures
    • Surgery
  2. By Procedure Type:
    • Transjugular Intrahepatic Portosystemic Shunt (TIPS)
    • Other Procedure Types
  3. By End-User:
    • Hospitals
    • Specialty Clinics
    • Other End-Users

Regional Insights

North America was the largest market for portal hypertension management in 2023, reflecting the region’s advanced healthcare infrastructure and high prevalence of liver diseases.

Request A Sample Of The Global Portal Hypertension Management Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16515&type=smp